Bohong Chen | Bioinformatics analysis | Best Researcher Award

Mr. Bohong Chen | Bioinformatics analysis | Best Researcher Award

Mr. Bohong Chen at The First Affiliated Hospital of Xi’an Jiaotong University, China

πŸ‘¨β€πŸŽ“Professional Profile

πŸ§‘β€πŸ”¬ Summary

Mr. Bohong Chen is a talented researcher from The First Affiliated Hospital of Xi’an Jiaotong University, China, currently pursuing his PhD with a focus on tumor drug resistance mechanisms, specifically for breast cancer. His work integrates transcriptomics, single-cell bioinformatics, and Mendelian randomization to better understand the molecular foundations of disease. With a strong academic background and multiple published articles in high-impact journals, Mr. Chen is well-equipped to contribute to foundational biomedical research aimed at improving cancer treatment strategies.

πŸ‘¨β€πŸŽ“ Education

Mr. Bohong Chen is currently pursuing a PhD at The First Affiliated Hospital of Xi’an Jiaotong University in China, where he focuses on exploring the mechanisms of tumor drug resistance, particularly for breast cancer. Prior to this, he earned his Master’s degree under the supervision of Wu Dapeng, equipping him with strong research skills in bioinformatics and molecular biology.

πŸ† Academic Honors

Mr. Chen has received several prestigious academic honors, including a Second-Class Scholarship for two consecutive years and the title of “Excellent Graduate Student” for the 2021 academic year. Additionally, he serves as a reviewer for the SCI journal PLOS ONE, demonstrating his academic contributions.

πŸ’» Technical Skills

With expertise in bioinformatics, Mr. Chen is proficient in using R Language for transcriptomic and single-cell data analysis. His skills also include Mendelian randomization, a method he uses for genetic epidemiology and to explore causal relationships in disease mechanisms. These technical skills form the backbone of his innovative research in tumor drug resistance and other medical conditions.

πŸ‘¨β€πŸ« Teaching Experience

In addition to his research, Mr. Chen has demonstrated teaching abilities as a Master’s Supervisor under Wu Dapeng. He assists graduate students in their research and offers valuable guidance in bioinformatics and genomics.

πŸ”¬ Research Interests

Mr. Chen’s research interests are primarily focused on understanding tumor drug resistance, especially in breast cancer. He is particularly interested in leveraging advanced bioinformatics techniques such as single-cell sequencing and machine learning to identify novel therapeutic targets. His goal is to provide more effective treatment strategies for cancer patients by exploring the molecular mechanisms behind drug resistance.

Liu Yang | Bioinformatics | Best Researcher Award

Prof Dr. Liu Yang | Bioinformatics | Best Researcher Award

Prof Dr. Liu Yang at Department of General Surgery, Jiangsu Cancer Hospital, China

πŸ‘¨β€πŸŽ“ Profile

πŸ‘¨β€βš•οΈ Current Position

Prof. Dr. Yang Liu is a Chief Physician and Associate Professor, serving as the Deputy Head of General Surgery at Jiangsu Cancer Hospital and the Head of Colorectal Surgery at Nanjing Medical University.

πŸ“œ Summary

Yang Liu is a prominent figure in colorectal surgery, also acting as a Master’s Supervisor and visiting overseas researcher at Thomas Jefferson University’s BluConner Hospital. His work has earned him multiple accolades in cancer research.

πŸŽ“ Education

Yang has completed his medical degree and advanced training in colorectal surgery, although specific institutions are not detailed here.

πŸ₯ Professional Experience

With a focus on complex minimally invasive surgeries, he performs over 150 advanced procedures annually and actively participates in various national and provincial medical associations.

πŸ”¬ Research Interests

His research primarily explores ncRNA genomics in relation to colorectal cancer progression and metastasis, alongside developing innovative surgical techniques.

πŸ’‘ Patents

Yang holds several patents, including:

  • 2024: Combination of Scutellarein for colorectal cancer treatment.
  • 2023: Multi-angle puncture holder.
  • 2020: Circ-0000423 for colorectal cancer drug development.
  • 2019: Surgical retractor for lower abdominal tumors.

πŸ† Awards

He has received notable awards such as:

  • 2021: 2nd Prize for New Medical Technology in Jiangsu for epigenetic fusion in colorectal cancer.
  • 2019: 2nd Prize for his study on LINC00152 in colorectal cancer.
πŸ“–Β  Top Noted Publications

LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3

  • Authors: Cao, Y., Zou, Z., Wu, X., Hu, J., Yang, L.
    Journal: Gene
    Year: 2024

Magnetic resonance imaging-based lymph node radiomics for predicting the metastasis of evaluable lymph nodes in rectal cancer

  • Authors: Ye, Y.-X., Yang, L., Kang, Z., Du, M., Li, Z.-X.
    Journal: World Journal of Gastrointestinal Oncology
    Year: 2024

Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies

  • Authors: Wang, N., Cao, Y., Si, C., Bao, J., Yang, L.
    Journal: Cancers
    Year: 2022

FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer

  • Authors: Li, D., Jiang, S., Zhou, X., Sun, Y., Yang, L.
    Journal: Frontiers in Oncology
    Year: 2022

Anal preservation on the psychology and quality of life of low rectal cancer

  • Authors: Mei, F., Yang, X., Na, L., Yang, L.
    Journal: Journal of Surgical Oncology
    Year: 2022